Michelson Diagnostics Company
Measure Morphologic and Angiographic Changes Visualize Skin Morphology to a Depth of > 1mm VivoSight DX visualise and quantify treatment effects for: Immune
Employee Number:
11-50
Funding Status:
Early Stage Venture
Headquarters:
Orpington, Bromley, United Kingdom
Technology:
Scientifically-Validated Lifestyle Recommendation
Founded Date:
2006
Investor Type:
N/A
Number Of Exists:
N/A
Investment Stage:
N/A
Industry:
Preventive Medicine